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Abstract 
Short-term exposure of human serum albumin to glucose in vitro results in the formation of fructosyllysine r sidues. Using short-term 
glucose-modified albumin the. interactions with human monocytes and with the human monocyte-like cells U937, MonoMac 6, HL60, and 
THP1 were studied. Short-term glycated albumin was specifically bound by monocytes, U937 and MonoMac 6 cells, but not by HL60 
and THP1 ceils. This specific binding of short-term glycated albumin was inhibited by fructosyllysine, but not by hexitollysine. 
Short-term glycated albumin did not compete for binding of albumin, modified by advanced glycation end products. Scatchard analysis of 
the binding data indicated that there are 10 000 binding sites per cell in monocytes or U937 cells and 2000 sites per cell on MonoMac 6 
cells with affinity constants ef 9 × 10 6 M- 1. Specific binding of short-term glycated albumin to human monocytes was observed in 29% 
of the 101 human subjects investigated. Ligand-receptor c oss-linking and ligand blotting experiments revealed two binding proteins of 
100 to 110 and 190 kDa in SDS-PAGE after membrane protein solubilization of U937 and MonoMac 6 cells. The binding of short-term 
glycated albumin to MonoMac 6 cells induced the production of the cytokines IL-1 and TNF. 
Keywords: Glycation; Receptor; Fructosyllysine; Monocyte; Monocyte like cells 
1. Introduction 
Proteins get modified under physiological conditions to 
some extent by glucose in a non-enzymatic reaction known 
as protein glycation. This process involves the condensa- 
tion between a reducing sugar, e.g., glucose, and an amino 
group to form a Schiff base, which may undergo an 
Amadori rearrangement to form a more stable ketoamine, 
e.g., fructosyllysine. Frnctosyllysine can generate ad- 
vanced glycation end products (AGE, Maillard adducts) by 
oxidative and non-oxidative processes [1,2]. 
AGE-modified proteins are recognized by specific cel- 
lular receptors, which results in receptor-mediated endocy- 
tosis and degradation by macrophages, transcytosis by 
endothelial cells and cytokine and growth factor produc- 
tion by monocytes, macrophages, fibroblasts, and mesan- 
gial cells of the kidney [3]. AGE-specific receptors have 
Abbreviations: AGE, advanced glycation end product; LPS lipopoly- 
saccharide; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gelelec- 
tropboresis; PBS, phosphate-buffered saline; TNF, tumor necrosis factor; 
IL-1, interleukin 1.
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been identified on macrophages, monocytes and liver 
membranes, which mediate uptake and degradation of 
these glucose-modified proteins and seem to be constitu- 
tively expressed [3-5]. These receptor-dependent vents 
have been postulated to be responsible for the development 
of age-related changes and vascular complications in 
chronic hyperglycemia. 
We have recently reported that a receptor exists on rat 
macrophages, which recognizes the Amadori product fruc- 
tosyllysine [6]. Because of this we have investigated the 
fructosyllysine ligand recognition by human monocytes 
and by human monocyte-like cell lines. Fructosyllysine 
receptors on monocytes were found in only 29% of hu- 
mans tested, in U937 and MonoMac 6 cells, but not in the 
HL60 and THP1 cell lines. 
2. Materials and methods 
2.1. Short-term glycated albumin 
Short-term glycated albumin was prepared as previously 
described [6] by incubating human albumin (fraction V, 
Sigma, Deisenhofen, Germany) with 100 mM glucose for 
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3 days at 37°C and pH 7.4 and isolated by boronic acid 
affinity chromatography. This glycated albumin contained 
about 1 mol fructose-lysine/mol protein and did not bind 
specifically to a bovine aortic endothelial cell line, which 
only recognized AGE-moieties in glucose-modified pro- 
teins [6]. For controls non-glycated and AGE-albumins 
were used. AGE-albumin was formed during 5 months 
incubation with 100 mM glucose at pH 7.4 and 37 ° C. 
Traces of glycation in normal albumin were removed by 
affinity chromatography on m-aminophenyl-boronate 
agarose (Sigma). Monomeric albumin was prepared by 
Sephadex G-200 gel chromatography. Proteins were la- 
beled with 125I using chloramine T [7] to a specific activity 
of 7000 to 10 000 cpm/ng protein. 
2.2. Materials 
Na125I, Hyperfilm HP and Hyperscreen were from 
Amersham-Buchler ,  Braunschweig,  Germany.  
Lipopolysaccharides (LPS) from Escherichia coli were 
purchased from Difco, Detroit, USA. Ficoll-Paque, Percoll 
and Sephadex were from Pharmacia, Freiburg, Germany. 
Leupeptin, pepstatin, soybean trypsin inhibitor, 3,-inter- 
feron, octyl-/3-glucoside and molecular weight protein 
standards (SDS-7B and color markers high range) were 
supplied by Sigma. Maleylated albumin, fructosyllysine 
and hexitollysine were prepared as previously described 
[6,8]. Mannose-albumin, where mannose was bound via 
divinylsulfone toalbumin (neoglycoprotein) [9] was a kind 
gift from Dr. P. Nehls, Institute of Medical Biochemistry, 
University of Rostock. 
Bis(sulfosuccinimidyl)suberate, nitrocellulose mem- 
branes and chemicals for sodium dodecylsulfate polyacryl- 
amide gel electrophoresis (SDS-PAGE) were from Serva, 
Heidelberg, Germany. Cell culture materials and the media 
RPMI 1640, Optimem I and fetal calf sera were obtained 
from Gibco, Berlin, and Nunc, Wiesbaden, Germany. 
All chemicals were at least of p.a. grade and commer- 
cially available from Sigma or Serva. 
2.3. Cells 
Human monocytes were prepared by Ficoll-Paque and 
Percoll density gradient centrifugation according to 
Gilcrease and Hoover [10]. Monocytes were enriched to 
60-80% purity as determined by morphology and non- 
specific esterase staining. Radioligand binding assays were 
performed immediately after purification of the cells. Hu- 
man monocyte-like cell lines U937 and MonoMac 6 were 
kindly provided by Dr. H. Dietz, Institute of Immunology, 
University Greifswald. HL60 and THP1 cells were a kind 
gift from Dr. H. Walzel, Institute of Medical Biochemistry, 
University Rostock, Germany. U937, HL60 and THP1 
cells were grown in RPMI 1640, containing 10% heat-in- 
activated fetal calf serum and 2% kanamycin. MonoMac 6 
cells were grown in Optimem I, containing 10% myoclone 
plus fetal calf serum, non-essential mino acids, 200 U/ml 
penicillin and 0.2 mg/ml streptomycin. After harvesting 
ligand binding was tested. 
2.4. Ligand-receptor interaction studies 
Binding assays were carried out in collagen-coated 
polyethylene tubes as described [6]. Shortly, the reaction 
mixture contained in a final volume of 0.2 ml 0.02 M Tris, 
0.15 M NaC1, 0.5 mM CaCl 2 (pH 7.4), about 500 000 
monocytes or 1 000 000 monocyte-like cells, 20 ng 125I- 
labeled albumins (5,000-8,000 cpm/ng) and indicated 
amounts of native or glycated albumins. Native, short- and 
long-term (AGE) glycated albumins, maleylated albumin, 
the neoglycoconjugate mannose-albumin, fructosyllysine, 
and hexitollysine were used as competitors. 
Incubation time was 4 h at 4 ° C. Under these conditions, 
ligand internalization and degradation is negligible, 
whereas at 37°C phagocytosis takes place [6]. Then, the 
cells were quickly pelleted by centrifugation (3 min, 800 
× g), washed with ice-cold PBS and recentrifuged. The 
cell pellet was dissolved in 0.2 ml 1 M NaOH for protein 
determination [11] and radioactivity counting. Non-specific 
binding was estimated from the radioactivity after an 
excess amount (1000-fold) of unlabeled ligand. 
Binding data were evaluated by Scatchard analysis us- 
ing the Enzfitter program (Elsevier-Biosoft). 
2.5. Cross-linking experiments 
Cross-linking of 125I-labeled glycated albumin to mono- 
cytic cells was performed according to Radoff et al. [12] 
with some modifications as described [6]. 0.1 mg labeled 
glycated albumin (specific activity 8000 cpm/ng) and 
2 X 108 cells were incubated at 4 ° C for 4 h. Then 0.6 
mg/ml bis(sulfosuccinimidyl)suberate wer  added and in- 
cubation continued for 30 min. After intensive washings 
(once with PBS, containing 1 mg/ml glycated albumin 
and five times with PBS for 2 h) the cells were homoge- 
nized in 2 ml PBS containing 1 mM phenylmethylsulfo- 
nyl-fluoride, 10/.~g/ml leupeptin, 10/~g/ml pepstatin, 10 
/zg/ml soybean trypsin inhibitor, 0.2 mg/ml EDTA. After 
centrifugation at 100 000 x g for 90 min the pellet was 
dissolved in 0.063 M Tris-HC1 (pH 6.8) containing the 
antiproteolytic agents and 1% Triton X-100 (v/v). The 
solution was again centrifuged at 100 000 X g for 90 min. 
After addition of SDS (2% (w/v) final concentration) 
the supernatants were analyzed by SDS-PAGE. Elec- 
trophoretic patterns were evaluated by autoradiography. 
For comparison, experiments were done with AGE-al- 
bumin using the same conditions, as described for short- 
term glycated albumin. 
2.6. Ligand blotting 
Crude membrane protein preparations from 2 x 10 8 
monocyte-like c lls were obtained as described above with 
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Fig. 1. Displacement of 125I-labeled glycated albumin from binding sites 
on human monocytes by different concentrations of glycated albumins 
(©), but not by native albumin (O). Data represent means+S.D, of 
triplicates of five different experiments. Values are corrected for non- 
specific binding determined in the presence of a 1000-fold excess of 
unlabeled protein. 
38 mM octyl-fl-glucoside as detergent and separated by 
SDS-PAGE on 4-15% gradient gels. Proteins were elec- 
trophoretically transferred from SDS slab gels onto nitro- 
cellulose paper. Non-specific binding sites on the nitro- 
cellulose filter were blocked in 10 mM Tris-HC1, pH 7.4, 
2% defatted milkpowder. Nitrocellulose strips were next 
incubated for 16 h at 4 ° C with 0.1 mg/ml 125I-labeled 
glycated albumin, extensively washed, and the radioactive 
proteins visualized by autoradiography. 
2. 7. Determination of cytokine production by monocyte-like 
cells in response to glycated albumin 
Tumor necrosis factor (TNF) and interleukin I (IL-lfl) 
production by U937, MonoMac 6 and HL60 cells (106/ml) 
was tested using the conditions described by Vlassara et al. 
[13]. Cells were incubated in media (RPMI 1640 plus 2% 
kanamycin or with Optimem I with 10% fetal calf serum) 
containing 100 ng/ml polymyxin B at 37°C for 24 h and 
were conditioned by the addition of 800 U/ml "y-inter- 
feron. LPS (20 or 30 ng/ml) and AGE-albumin (0.25 
mg/ml) were used as positive controls. Native albumin 
(0.25 and 0.5 mg/ml) and medium without ligands served 
as negative controls. Short-term glycated albumin was 
tested in the concentration of 0.25 and 0.5 mg/ml. TNF 
and IL-1 fl were detected by ELISA (Medgenix, Fleurus, 
Belgium; Biochrom, Berlin, Germany) in culture media. 
Experiments were performed with MonoMac 6 cells, which 
were grown in Optimem I with 10% fetal calf serum, 
because cells were damaged by incubation in medium 
without serum supplementation. 
3. Results 
3.1. Binding studies with 125I-labeled glycated albumins 
The binding reaction of glycated albumin with sites on 
freshly isolated monocytes reaches equilibrium within 4 h 
at 4 ° C. 125I-labeled glycated albumin was displaced from 
its binding sites by non-labeled glycated albumin, but not 
by native albumin and albumin, incubated with buffer in 
the absence of glucose (Fig. 1). After incubation of the 
cells with increasing amounts of glycated albumin the 
binding increased in a saturable fashion. Scatchard analysis 
yielded a K a = 9.3 × 10 6 M -1 and 5000 to 10 000 sites 
per cell (Fig. 2). Such binding sites were identified in 29% 
of the investigated humans (n = 101). 
The binding behavior of monocytes was not dependent 
on age and sex and could not be changed by preincubation 
with LPS. 
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Fig. 2. Specific binding of 125I-labeled glycated albumin to monocytes. 
The saturation binding profile was obtained by incubating monocytes 
with different concentrations of glycated albumins at 4 ° C for 4 h. 
Non-specific binding was determined in the presence of a 1000ffold 
excess of unlabeled glycated albumin. Data are means of triplicate 
determinations of five independent experiments (upper part). Scatchard 
plot analysis of binding data (lower part). 
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Fig. 3. Competition of 125I-labeled AGE-albumin from binding sites on 
human monocytes, deficient for fructosyllysine specific receptors, by 
AGE-albumin (O), but not by short-term glycated albumin (•) .  Data 
represent means + S.D. and were calculated from triplicate assays of five 
different experiments. Non-specific binding was determined in the pres- 
ence of a 1000-fold excess of unlabeled AGE-albumin. 
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Fig. 4. Displacement of z25I-labeled glycated albumin from binding sites 
on U937 (O-O), HL60 (D-El), and MonoMac 6 cells (v-xT) by 
different concentrations of glycated albumin. Data were obtained from 
triplicate assays of six different experiments (U937, MonoMac 6) or three 
independent i vestigations (HL60) and were expressed as means + S.D. 
THP1 cells showed similar esults as with HL60 cells. 
fates, glucose, fructose, and L-lysine did not displace 
radiolabeled glycated albumin from its binding sites (data 
not shown). 
Monocytes, which did not show binding sites for short- 
term glycated albumin, bound 125I-labeled AGE-albumin. 
Short-term glycated albumin did not compete with the 
binding of AGE-albumin. This indicates that sites for AGE 
and Amadori adducts are not identical (Fig. 3). 
We also investigated the monocyte-like cell lines U937, 
MonoMac 6, THP1 and HL60, which retain some mono- 
cyte characteristics, for binding sites. 
THP1 and HL60 cells did not bind glycated albumin 
specifically. MonoMac 6 cells showed a weak specific 
binding. The binding behaviour of U937 was very similar 
to monocytes (Fig. 4). Scatchard analysis revealed a K a = 
9.6 X 106 M -1 and 8000 to 10 000 sites per cell. Mono- 
Mac 6 cells had fewer binding sites (n = 2,000/cel l )  of 
similar affinity. Fructosyllysine was competitive in a con- 
centration dependent manner in binding studies with gly- 
cated albumin on U937 cells and monocytes. But in com- 
parison with monocytes, an initial increased binding at low 
competitor concentrations, as it was also demonstrable by 
rat macrophages [6], could not be observed. Hexitollysine 
was not competitive (Fig. 5). 
3.2. L igand receptor cross-linking 
Chemical cross-linking of binding sites with 125I-labeled 
short-term glycated albumin showed two protein bands 
with molecular masses of 260 and 160 kDa only in mem- 
brane preparations of U937 and MonoMac 6 cells, but not 
in THP1 and HL60 cell membranes (Fig. 6), confirming 
results from the binding studies. Molecular masses of 
about 190 and 90 kDa were calculated for the binding 
proteins by subtracting the molar mass of albumin. Identi- 
cal results were obtained when the proteins were reduced 
by mercaptoethanol prior to electrophoresis. 
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Fig. 5. Effect of fructosyllysine (O U937, • monocytes) and hcxitol- 
lysine (v U937) on the binding of 1251-labeled glycated albumin by 
monocytes and U937 cells. Cells were incubated with different concentra- 
tions of the competitors for 4 h at 4 ° C. Data are expressed as means of 
five experiments each performed in triplicate. Standard eviations were 
less than 10% of the means. 
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Fig. 6. Autoradiogram of SDS-PAGE analysis of bis(sulfosuceinimidyl)- 
subemte cross-linked 12s I-labeled giycated albumin to membrane proteins 
of U937 (lane 1), MonoMac 6 (lane 2), HL60 (lane 3), and THP1 (lane 4) 
cells. Lane 1:0.05 mg membrane protein; lane 2 to 4:0.2 mg membrane 
protein. SDS-PAGE was performed on a 4-15% gradient gel. Membrane 
proteins were solubilized with 1% (v/v) Triton X-100. The protein 
fraction with the highest mobilhy (67 kDa) is non-cross-linked 125I-al- 
bumin. The scale used to estimate the molecular masses of proteins is 
depicted on the left side of the figure in kDa. 
After incubation of radiolabeled glycated albumin with 
solubil ized U937 membrane proteins (38 mM octyl-fl-glu- 
coside) and chemical cross-l inking again only the 260 and 
160 kDa proteins were detectable as a result of receptor 
l igand interactions. 
For comparison, cross-l inking of AGE and short-term 
glycated albumin to theiir b inding sites on U937 cell 
membranes was performed in parallel under similar condi- 
tions. With AGE-a lbumin only a weak 90 kDa protein 
fraction (subtraction of the albumin mass) was found, 
whereas with glycated albumin the 190 kDa protein and 
the prominent 90 kDa fraction (albumin molecular mass 









Fig. 7. Autoradiogram of SDS-.PAGE, using 4-15% gradient gels, of 
125 bis(sulfosuccinimidyl)suberate cross-linked I-labeled AGE-albumin 
(lane 1; 0.05 mg membrane protein) and 125I-labeled short-term glycated 
albumin (lane 2; 0.05 mg membrane protein) to U937 cell membranes. 
Membrane proteins were solubilized with 1% Triton X-100 (v/v). Esti- 
mates of relative molecular masses are according to the scale of marker 




Fig. 8. Ligand blot detection of binding proteins for short-term glycated 
albumin. U937 cell membranes (108 cells) were solubilized with 1% 
(w/v) octyl-/3-glucoside. 0.3mg membrane protein were electrophoresed 
on a 4-15% SDS gradient gel. Separated proteins were electrophoretically 
• • - 125  transferred to a mtrocellulose membrane, mcubated with I-labeled 
glycated albumin and visualized by autoradiography. Determination of
molecular masses is as described in Fig. 6. 
3.3. Ligand blotting 
After direct ligand blotting two protein fractions with 
molecular masses of 190 to 200 kDa and 100 to 110 kDa 
were demonstrable using membrane preparations from 
U937 and MonoMac 6 cells, but not with HL60 and THP1 
cell membranes (Fig. 8). The differences in the mol mass 
estimates between cross-l inking experiments and l igand 
blotting are due to the greater accuracy of the estimates in 
lower molecular weight ranges. In some membrane protein 
preparations fractions with mol masses of 155 kDa could 
also be found. Fructosyllysine binding proteins were only 
detected by l igand blotting when the membrane proteins 
were solubil ized by octylglucoside instead of Triton X-100 
and were not reduced by SH-reagents for electrophoresis. 
3.4. Cytokine production by monocyte-like cells 
A stimulated TNF  and IL-1 production by human 
monocytes in response to AGE-b ind ing has been reported 
[13]. We tested the monocyte-l ike cell l ines U937, Mono- 
Mac 6, and HL60 for such a response towards short-term 
glycated albumin. 
Table 1 
IL-1/3 secretion of MonoMac 6 cells exposed to glycated albumins 
Ligand (pg/ml) 
LPS (30 ng/ml) 
AGE-albumin (0.25 mg/ml) 
Native albumin (0.25 mg/ml) 
Native albumin (0.5 mg/ml) 
Glycated albumin (0.25 mg/ml) 
Glycated albumin (0.5 mg/ml) 
No ligands 
30.9 + 0.9 
14.2 -t- 2.0 P < 0.01 
9.7-t-1.9 
11.6 + 3.5 
19.7 + 7.0 P < 0.025 
60.8 -t- 1.5 P < 0.001 
10.3 + 1.2 
Data are means +S.D. from 4 experiments. 
P was calculated from a t-test. 
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Table 2 
TNF secretion ofMonoMac 6cells after exposure toglycated albumins 
Ligand pg/ml 
LPS (30 ng/ml) 
AGE-albumin (0.25 mgl/ml) 
Native albumin (0.25 mg/ml) 
Native albumin (0.5 mgl/ml) 
Glycated albumin (0.25 mg/ml) 
Glycated albumin (0.5 mg/ml) 
No ligands 
236.0 + 21.0 
161.7+18.6 
162.6 + 19.6 
178.3 + 22.2 
203.4 + 4.0 P < 0.001 
233.9 + 1.4 P < 0.001 
158.2+15.6 
Data are means +S.D. from 4 experiments. 
P was estimated using a t-test. 
TNF and IL-1 production by U937 and HL60 cells 
(CD14 negative) was not affected by LPS, AGE- and 
short-term glycated albumins. Also MonoMac 6 cells, not 
supplemented with fetal calf sera, did not secrete TNF and 
IL-1 in significant concentrations. There was, however, a 
stimulus-dependent IL-1 secretion with MonoMac 6 cells 
in the presence of sera (Table 1). Short-term glycated 
albumin was an efficient stimulant of IL-1 secretion. Expo- 
sure to LPS, AGE- and short-term glycated albumin also 
caused a moderate increase of cell-associated TNF. How- 
ever, TNF secretion in response to glycated albumin in- 
creased when the medium was supplemented with 10% 
fetal calf serum (Table 2). 
4. Discussion 
In this study we report the characterization of the 
fructosyllysine r ceptor on human monocytes and human 
monocyte-like c lls. 
Human monocytes possess fructosyllysine specific bind- 
ing sites, which bind glycated albumin in a similar fashion 
as it had been shown for rat macrophages [6]. However, 
these binding proteins were expressed on monocytes of 
only 29% of the healthy persons investigated. The binding 
behavior was not age- and sex-dependent and could not be 
changed by incubation with LPS. In accordance with this 
result it was found that not all monocyte-like c ll lines had 
the specific ability to recognize short-term glycated albu- 
min. 
The specificity of this newly described receptor site is 
evidenced by the competition experiments with glycated 
albumin and fructosyllysine and the lack of displacement 
with native albumin, hexitollysine, mannose-neog- 
lycoprotein and maleylated albumin. Short-term glycated 
albumin did not compete for binding of AGE-albumin, 
indicating that AGE and fructosyllysine binding sites are 
not identical [4-6,12,14,15]. 
This view is supported by results from molecular weight 
determination of the receptor proteins by cross-linking 
experiments and ligand blot detection. Approximate M r of 
190 000 and 100 000 to 110 000 have been deduced for 
the fructosyllysine-specific s tes on the monocytic cell 
lines U937 and MonoMac 6. The binding proteins for 
AGE-albumin on monocytes and macrophages have M r of 
90,000 and 60,000 [3,12,14,15]. The experiments of this 
and previous studies [4-6,14,15] led us to assume that 
these receptors are not identical. 
For comparison, the receptor for formaldehyde-modified 
albumin is a glycoprotein of M r --- 125,000 [16]. A M r of 
220 000 has been reported for macrophage scavenger 
receptor [17]. All these receptors, as well as the AGE 
binding proteins are constitutively expressed in contrast to 
the fructosyllysine specific sites. 
Two proteins of M r of 110,000 and 205,000 with an 
ability to bind glycated albumin have been recently identi- 
fied on murine aortic endothelial cells [18,19]. These re- 
suits are in close agreement with our data. 
Vlassara et al. [13] have demonstrated that AGE-al- 
bumin can stimulate monocytes to synthesize and secrete 
the cytokines IL-1 and TNF in a dose-dependent manner. 
Our data indicate that not only AGE-proteins, but also 
Amadori adducts, stimulate monocytes to produce cy- 
tokines. MonoMac 6, the most differentiated monocyte-like 
cell line used, was able to produce TNF and IL-1 after 
binding of short-term glycated albumin. It was supposed 
that the release of these cytokines may play a role in tissue 
remodeling in the development of diabetic vascular com- 
plications. However, the pathways by which these complex 
phenomena are processed are not known [3,4,13]. 
This work on the specific recognition of 
fructosyllysine-proteins by receptors on monocytes and 
macrophages and the cellular response to this interaction 
serves as a starting point for future studies of the proper- 
ties of these fructosyllysine binding proteins and of their 
physiological importance. 
The supposition is interesting that different rates of 
development of complications in diabetic patients with 
similar degrees of hyperglycemia may be a result of 
genetic variability in the expression of fructose-lysine spe- 
cific receptors which can remove Amadori adducts as 
sources for the dangerous AGEs. But this hypothesis de- 
mands further esearch. 
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